These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
304 related articles for article (PubMed ID: 11549382)
1. Up-regulation of spinal mu-opioid receptor function to activate G-protein by chronic naloxone treatment. Narita M; Mizoguchi H; Nagase H; Suzuki T; Tseng LF Brain Res; 2001 Sep; 913(2):170-3. PubMed ID: 11549382 [TBL] [Abstract][Full Text] [Related]
2. Absence of G-protein activation by mu-opioid receptor agonists in the spinal cord of mu-opioid receptor knockout mice. Narita M; Mizoguchi H; Narita M; Sora I; Uhl GR; Tseng LF Br J Pharmacol; 1999 Jan; 126(2):451-6. PubMed ID: 10077238 [TBL] [Abstract][Full Text] [Related]
3. Heterologous mu-opioid receptor adaptation by repeated stimulation of kappa-opioid receptor: up-regulation of G-protein activation and antinociception. Narita M; Khotib J; Suzuki M; Ozaki S; Yajima Y; Suzuki T J Neurochem; 2003 Jun; 85(5):1171-9. PubMed ID: 12753076 [TBL] [Abstract][Full Text] [Related]
4. Involvement of spinal protein kinase Cgamma in the attenuation of opioid mu-receptor-mediated G-protein activation after chronic intrathecal administration of [D-Ala2,N-MePhe4,Gly-Ol(5)]enkephalin. Narita M; Mizoguchi H; Narita M; Nagase H; Suzuki T; Tseng LF J Neurosci; 2001 Jun; 21(11):3715-20. PubMed ID: 11356858 [TBL] [Abstract][Full Text] [Related]
5. Stimulation of guanosine-5'-o-(3-[35S]thio)triphosphate binding in digitonin-permeabilized C6 rat glioma cells: evidence for an organized association of mu-opioid receptors and G protein. Alt A; McFadyen IJ; Fan CD; Woods JH; Traynor JR J Pharmacol Exp Ther; 2001 Jul; 298(1):116-21. PubMed ID: 11408532 [TBL] [Abstract][Full Text] [Related]
6. Mu opioid receptor efficacy and potency of morphine-6-glucuronide in neonatal guinea pig brainstem membranes: comparison with transfected CHO cells. Gray RE; Munks MW; Haynes RR; Olsen GD Brain Res Bull; 2001 Mar; 54(5):499-505. PubMed ID: 11397539 [TBL] [Abstract][Full Text] [Related]
7. G protein activation by endomorphins in the mouse periaqueductal gray matter. Narita M; Mizoguchi H; Narita M; Dun NJ; Hwang BH; Endoh T; Suzuki T; Nagase H; Suzuki T; Tseng LF J Biomed Sci; 2000; 7(3):221-5. PubMed ID: 10810240 [TBL] [Abstract][Full Text] [Related]
8. Lack of the involvement of mu1-opioid receptor subtype on motivational effects induced by the endogenous mu-opioid receptor ligands endomorphin-1 and -2 in the mouse. Narita M; Ozaki S; Ioka M; Mizoguchi H; Nagase H; Tseng LF; Suzuki T Neurosci Lett; 2001 Jul; 308(1):17-20. PubMed ID: 11445275 [TBL] [Abstract][Full Text] [Related]
9. [(35)S]GTPĪ³S binding and opioid tolerance and efficacy in mouse spinal cord. Madia PA; Navani DM; Yoburn BC Pharmacol Biochem Behav; 2012 Mar; 101(1):155-65. PubMed ID: 22108651 [TBL] [Abstract][Full Text] [Related]
10. Direct evidence for the up-regulation of spinal micro-opioid receptor function after repeated stimulation of kappa-opioid receptors in the mouse. Narita M; Khotib J; Mizoguchi H; Suzuki M; Ozaki S; Yajima Y; Tseng LF; Suzuki T Eur J Neurosci; 2003 Nov; 18(9):2498-504. PubMed ID: 14622150 [TBL] [Abstract][Full Text] [Related]
11. Antagonistic property of buprenorphine for putative epsilon-opioid receptor-mediated G-protein activation by beta-endorphin in pons/medulla of the mu-opioid receptor knockout mouse. Mizoguchi H; Wu HE; Narita M; Hall FS; Sora I; Uhl GR; Nagase H; Tseng LF Neuroscience; 2002; 115(3):715-21. PubMed ID: 12435410 [TBL] [Abstract][Full Text] [Related]
12. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors. Zhao GM; Qian X; Schiller PW; Szeto HH J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366 [TBL] [Abstract][Full Text] [Related]
13. Chronic exposure to mu-opioid agonists produces constitutive activation of mu-opioid receptors in direct proportion to the efficacy of the agonist used for pretreatment. Liu JG; Prather PL Mol Pharmacol; 2001 Jul; 60(1):53-62. PubMed ID: 11408600 [TBL] [Abstract][Full Text] [Related]
14. Differential involvement of mu(1)-opioid receptors in endomorphin- and beta-endorphin-induced G-protein activation in the mouse pons/medulla. Mizoguchi H; Narita M; Wu H; Narita M; Suzuki T; Nagase H; Tseng LF Neuroscience; 2000; 100(4):835-9. PubMed ID: 11036217 [TBL] [Abstract][Full Text] [Related]
15. The spinal antinociceptive effects of endomorphins in rats: behavioral and G protein functional studies. Xie H; Woods JH; Traynor JR; Ko MC Anesth Analg; 2008 Jun; 106(6):1873-81. PubMed ID: 18499626 [TBL] [Abstract][Full Text] [Related]
16. Endomorphin-stimulated [35S]GTPgammaS binding in rat brain: evidence for partial agonist activity at mu-opioid receptors. Sim LJ; Liu Q; Childers SR; Selley DE J Neurochem; 1998 Apr; 70(4):1567-76. PubMed ID: 9523574 [TBL] [Abstract][Full Text] [Related]
17. Relationship of mu opioid receptor binding to activation of G-proteins in specific rat brain regions. Maher CE; Selley DE; Childers SR Biochem Pharmacol; 2000 Jun; 59(11):1395-401. PubMed ID: 10751548 [TBL] [Abstract][Full Text] [Related]
18. Acute and chronic effects of opioids on delta and mu receptor activation of G proteins in NG108-15 and SK-N-SH cell membranes. Breivogel CS; Selley DE; Childers SR J Neurochem; 1997 Apr; 68(4):1462-72. PubMed ID: 9084416 [TBL] [Abstract][Full Text] [Related]
19. Up-regulation of mu-opioid receptor-mediated G-protein activation in protein kinase Cgamma knockout mice following repeated naloxone treatment. Narita M; Suzuki M; Mizoguchi H; Narita M; Yajima Y; Sakurada S; Tseng LF; Suzuki T Neurosci Lett; 2003 Feb; 338(2):103-6. PubMed ID: 12566163 [TBL] [Abstract][Full Text] [Related]
20. Blockade of mu-opioid receptor-mediated G-protein activation and antinociception by TRK-820 in mice. Mizoguchi H; Hung KC; Leitermann R; Narita M; Nagase H; Suzuki T; Tseng LF Eur J Pharmacol; 2003 Feb; 461(1):35-9. PubMed ID: 12568913 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]